Why Are Ransomware Attacks on Retail So Common?

We’ve all seen those suspicious emails that show up in our inboxes: “Is this picture of you?” they’ll ask, as we hover over that link for just a moment. Now more than ever, companies are aware and preparing for digital threats and data breaches. Despite that, or perhaps because of it, year after year both the amount and the sophistication of digital attacks increases. According to IBM’s 2022 report on the cost of a data breach, the global average cost for a data breach was a record-breaking $4.35 million, a figure that’s risen nearly 13% just in the last year. For ecommerce and big box retailer professionals who might be wondering, do these trends match up to the data behind ransomware attacks on retail?

When it comes to who bad actors are targeting, it seems more are turning to the retail industry as an industry ripe for exploitation. Research out of cybersecurity and device data privacy firm BlackFog, which catalogs the rate of retail sector cybersecurity breaches yearly, found that ransomware attacks on retail increased by 67% in 2022, year-over-year. Compared to 2020, the increase was even more substantial, growing by 233%.

Daniel Pigeon, the senior product marketing manager at Cyberint, explains why ransomware attacks on retail might be growing in prominence and where hackers are finding vulnerabilities to take advantage of.

Daniel’s Thoughts:

“In 2022, the retail industry was the third most targeted industry for ransomware attacks, and 14% of all ransomware attacks that the Cyberint team observed were on retail industry organizations. So, this raises an important question, which is why are threat actors in ransomware groups targeting the retail industry?

From our research at Cyberint, we believe that there’s two primary reasons. First of all, when threat actors target and attack retail industry organizations, they don’t receive nearly as much negative attention from the media or from law enforcement as when they attack other industries such as healthcare, education, government, and critical infrastructure.

The second reason is that retail industry companies tend to have a weaker cybersecurity posture compared to other industries like technology, banking and insurance. This makes the retail industry a great target as threat actors don’t need to put in as much effort to compromise their victims. We’ve seen threat actors with a relatively low level of sophistication successfully compromise and attack retail industry companies.

The main attack vectors that we’re seeing are vulnerability exploitation of old and unpatched software, phishing attacks that target both the retail organization’s employees as well as the retail organization’s customers, and finally malware: specifically, a type of malware called infostealers, which steal credentials and other sensitive data from the victim’s browser.”

Article written by Graham P. Johnson.

Follow us on social media for the latest updates in B2B!

Image

Latest

vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More
cancer
Targeting T Cells Within the Cancer Immunity Cycle
April 19, 2025

As cancer immunotherapy continues to reshape treatment landscapes, fine-tuning T-cell responses has become a critical frontier. Recent advances in 3D organoid models and high-content imaging are enabling scientists to closely mimic patient-specific tumor environments—unlocking insights into how T cells behave, respond, and falter under immune checkpoint blockade. With over 4,000 immune modulators in clinical…

Read More
cancer Immunity cycle
Advanced In Vitro Technologies to Investigate Therapeutic Impact on the Cancer Immunity Cycle
April 19, 2025

As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…

Read More
resistance
Inside Oncology Drug Development: Overcoming Resistance with Science
April 19, 2025

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

Read More